Despite amitriptyline missing the primary endpoint of significantly improving pain relief, disability, and work-related outcomes at 6 months for people with chronic low back pain, shorter term ...

UPDATE: April 29, 2021 – Second lot recalled due to presence of nitrosamine impurity Apotex Inc. is recalling a second lot of APO-Amitriptyline 10 mg tablets (lot PY1831, expiry 12/2023), after ...

Although treatment with low-dose amitriptyline did not achieve a significant difference in improvement of pain or work outcomes among patients with chronic low back pain at 6 months, it did reduce ...

The largest contributor to global disability is low back pain, for which various treatments are available but are of limited efficacy. International clinical guidelines recommend low-dose ...

Titrated low-dose amitriptyline significantly improved irritable bowel syndrome (IBS) symptoms when used as a second-line treatment in the primary care setting, the randomized ATLANTIS trial showed.

Amitriptyline is a prescription drug available as a tablet in several strengths. It’s approved for use to treat depression but is also often prescribed for several other conditions like pain, ...

Apotex Inc. is recalling one lot of APO-Amitriptyline 10 mg tablets after testing identified levels of N-nitrosodimethylamine (NDMA) above what is considered acceptable if the drug were to be taken ...